Hiroki Nakamura1, Davina Henderson2, Prem Puri3,4. 1. National Children's Research Centre, Our Lady's Children's Hospital, Dublin, Ireland. hinakamu@juntendo.ac.jp. 2. Royal College of Surgeons in Ireland, 123 St. Stephens Green, Dublin 2, Ireland. 3. National Children's Research Centre, Our Lady's Children's Hospital, Dublin, Ireland. 4. School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
Abstract
AIM OF THE STUDY: Total intestinal aganglionosis (TIA) occurs in less than 1% of patients with Hirschsprung disease (HD), and TIA is the most severe form of HD. Survival has improved with the advent of parenteral nutrition and intestinal transplantation (ITx). The field of ITx has rapidly progressed in the last two decades and has now become an established treatment for patients with intestinal failure. The purpose of this meta-analysis was to determine the clinical outcome of ITx in patients with TIA. METHODS: A systematic literature search for relevant articles was performed in four databases using the combinations of the following terms: "total intestinal aganglionosis", "intestinal transplantation", and "Hirschsprung disease/Hirschsprung's disease" for studies published between 2003 and 2016. The relevant cohorts of ITx in patients with TIA were systematically searched for clinical outcomes. MAIN RESULTS: Thirteen studies met defined inclusion criteria, reporting a total of 63 patients who underwent ITx for TIA. Majority of patients were males (71.0%), and median age of ITx was 4.3 (range 0.25-17.6) years. Isolated ITx was performed in 37% patients and multivisceral ITx in 63%. Mean follow-up period was 40 months (range 1-154). Overall survival rate was 66%; the longest survivor was 12.8-year-old after ITx. CONCLUSION: ITx appears promising in the management of TIA. ITx can be considered a feasible treatment option for patients with TIA who suffer from life-threatening complications of intestinal failure.
AIM OF THE STUDY: Total intestinal aganglionosis (TIA) occurs in less than 1% of patients with Hirschsprung disease (HD), and TIA is the most severe form of HD. Survival has improved with the advent of parenteral nutrition and intestinal transplantation (ITx). The field of ITx has rapidly progressed in the last two decades and has now become an established treatment for patients with intestinal failure. The purpose of this meta-analysis was to determine the clinical outcome of ITx in patients with TIA. METHODS: A systematic literature search for relevant articles was performed in four databases using the combinations of the following terms: "total intestinal aganglionosis", "intestinal transplantation", and "Hirschsprung disease/Hirschsprung's disease" for studies published between 2003 and 2016. The relevant cohorts of ITx in patients with TIA were systematically searched for clinical outcomes. MAIN RESULTS: Thirteen studies met defined inclusion criteria, reporting a total of 63 patients who underwent ITx for TIA. Majority of patients were males (71.0%), and median age of ITx was 4.3 (range 0.25-17.6) years. Isolated ITx was performed in 37% patients and multivisceral ITx in 63%. Mean follow-up period was 40 months (range 1-154). Overall survival rate was 66%; the longest survivor was 12.8-year-old after ITx. CONCLUSION:ITx appears promising in the management of TIA. ITx can be considered a feasible treatment option for patients with TIA who suffer from life-threatening complications of intestinal failure.
Entities:
Keywords:
Intestinal transplantation; Total intestinal aganglionosis
Authors: Giuseppe M Rovera; Robert E Schoen; Beth Goldbach; Douglas Janson; Geoffrey Bond; Jorge Rakela; Toby O Graham; Stephen O'Keefe; Kareem Abu-Elmagd Journal: JPEN J Parenter Enteral Nutr Date: 2003 Jul-Aug Impact factor: 4.016
Authors: Karim C El Kasmi; Aimee L Anderson; Michael W Devereaux; Sophie A Fillon; J Kirk Harris; Mark A Lovell; Milton J Finegold; Ronald J Sokol Journal: Hepatology Date: 2012-03-18 Impact factor: 17.425
Authors: Thomas M Fishbein; Sander Florman; Gabriel Gondolesi; Thomas Schiano; Neal LeLeiko; Allan Tschernia; Stuart Kaufman Journal: Transplantation Date: 2002-05-27 Impact factor: 4.939
Authors: Akemi L Kawaguchi; Yigit S Guner; Stig Sømme; Alexandria C Quesenberry; L Grier Arthur; Juan E Sola; Cynthia D Downard; Rebecca M Rentea; Patricia A Valusek; Caitlin A Smith; Mark B Slidell; Robert L Ricca; Roshni Dasgupta; Elizabeth Renaud; Doug Miniati; Jarod McAteer; Alana L Beres; Julia Grabowski; Shawn D St Peter; Ankush Gosain Journal: J Pediatr Surg Date: 2021-03-28 Impact factor: 2.549
Authors: Wendy Yang; Jenny Pham; Sebastian K King; Donald F Newgreen; Heather M Young; Lincon A Stamp; Marlene M Hao Journal: Biomolecules Date: 2022-08-10
Authors: Yi Zheng; ChaoTing Lan; Ning Wang; Xiaogang Xu; Tuqun Hu; Qi Wu; Xiaoli Xie; Zhe Wang; Yan Zhang; Cong Li Journal: Biomed Res Int Date: 2020-10-31 Impact factor: 3.411